To compare grafting biomaterials or biological agents plus open flap debridement (OFD) with OFD alone for the treatment of deep intraosseous defects.
Assessment of study quality
Validity was assessed on the basis of randomisation, allocation concealment and blinding of the examiners and therapists. The review also assessed the completeness of follow-up. Two reviewers independently assessed validity and the results were entered onto a specifically designed form. Inter-reviewer agreement was assessed using the kappa statistic.
Data extraction
One reviewer extracted data onto a computer. The variance was estimated for studies that did not report standard deviations. For studies in which inter-radicular defects were combined with intraosseous defect, only data for the intraosseous parts were included in the analysis. Only studies that reported the variance, or that presented adequate data for its estimation, were included in the meta-analysis. Trials with three treatment arms were split and each grafting treatment was compared with the same control group.
Methods of synthesis
How were the studies combined? The studies were combined in meta-analyses according to the type of biomaterial or biological agent. Weighted mean differences (WMD) and 95% confidence intervals (CIs) were calculated for continuous outcomes. The studies were combined using random-effect models where significant heterogeneity was detected (P<0.05) and fixed-effect models otherwise.
How were differences between studies investigated?
Statistical heterogeneity was assessed and forest plots were presented. Heterogeneity was explored, where appropriate, using Galbraith plots and meta-regression.
Results of the review
Twenty-six RCTs (605 patients with 1,306 intraosseous defects) were included.
Ten RCTs reported adequate methods of randomisation. Five RCTs reported adequate allocation concealment. Seven RCTs reported blinded outcome assessment and two RCTs reported blinding of the therapist. One RCT reported information on all randomised patients. CAL gain.
ABG (1 RCT): the study showed that ABG increased CAL gain but the increase was not statistically significant, 3.2 mm versus 2.0 mm (P>0.20).
Bone allograft (6 RCTs): the meta-analysis showed that bone allograft increased CAL gain but the increase was not statistically significant; the WMD was 0.36 mm (95% CI: -0.16, 0.87). Significant heterogeneity was detected (P=0.01). The Galbraith plot showed that the results from one RCT differed from the others.
Dentin allograft (1 RCT): the study showed no significant difference in CAL gain between treatments, 2.8 mm with graft versus 2.0 mm with controls (P>0.5).
CCC (4 RCTs): the meta-analysis showed that CCC significantly increased CAL gain; the WMD was 0.90 mm (95% CI: 0.53, 1.27). No significant heterogeneity was detected (P=0.10).
Bioactive glass (4 RCTs): the meta-analysis showed that bioactive glass significantly increased CAL gain; the WMD was 1.04 mm (95% CI: 0.31, 1.76). Significant heterogeneity was detected (P=0.02).
